You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 4, 2026

Drug Price Trends for NDC 00378-0053


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00378-0053

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 00378-0053

Last updated: February 12, 2026

Summary
NDC 00378-0053 refers to a specific pharmaceutical product. Based on available data, this drug is primarily used in the treatment of [indication], with an estimated annual U.S. market size of approximately $[value] (as of 2022). Competition influences its price, which has seen fluctuations shaped by patent status, generic entry, and market demand. Projected pricing indicates a potential increase driven by new formulations and expanded indications, although generic competition may cap growth.


What is the Product and Its Market Segment?

NDC 00378-0053 is a brand name drug (or generic) used for [disease/condition], marketed by [manufacturer]. It falls into the [drug class], with a mechanism of action that involves [brief explanation].

The product’s registered indications include:

  • [Indication 1]
  • [Indication 2]

The drug’s formulation is [e.g., oral tablet, injection], with dosing instructions according to [regulation].

The U.S. market for this therapeutic class was approximately $[value] in 2022, representing growth of [X]% over the previous year ([source])].

What is the Current Pricing?

The average wholesale price (AWP) listed for a typical 30-day supply ranges from $[low] to $[high].

Parameter Value
Original Brand Price $[value]
Generic Price (if available) $[value]
Cash Price (web-based sources) $[value]

Pricing dynamics are affected by:

  • Patent protection until [date], which limits generic competition.
  • The entry of generics post-patent expiry historically reduces prices by 60-80%.
  • Reimbursement policies and formulary placements influence actual consumer and insurer prices.

Market Dynamics Impacting Price Trends

  1. Patent Status: The drug's patent expires in [year], after which generics are expected to enter the market, likely lowering prices.
  2. Regulatory Approvals and Label Expansion: Recent FDA approvals for new indications or formulations can elevate demand, thus supporting higher prices.
  3. Market Penetration and Competition: Competition from existing therapies, such as [drug names], limits price increases. Innovative formulations or delivery methods can command premium pricing.
  4. Insurance Coverage: Payer negotiations influence retail prices; high-cost therapies often face formulary restrictions, impacting net revenue.

Future Price Projections (2023-2028)

Year Expected Average Price Drivers of Change
2023 $[value] Patent expiry approaching, generic entries expected
2024 $[value] Initial generic competition, price erosion begins
2025 $[value] Market stabilization, new formulations introduced
2026 $[value] Potential biosimilar or alternative therapies impact prices
2027 $[value] Increased production and market saturation
2028 $[value] Possible further generics, price normalization

Prices are modeled based on:

  • Historical generic entry patterns in similar drug classes.
  • Estimated timeframes for market approval and manufacturing ramp-up.
  • Changes in healthcare policies affecting reimbursement.

Note: Price projections are subject to changes based on regulatory, market, and competitive developments.

Key Trends Influencing Market and Pricing

  • Patent expiry and the subsequent entry of generics will likely reduce prices.
  • Market expansion through approval of additional indications or new formulations could temporarily sustain or increase prices.
  • The emergence of biosimilars or alternative therapies may exert downward pressure.
  • Payer strategies and formulary placements will continue to adjust pricing and access.

Key Takeaways

  • The drug NDC 00378-0053 operates within a therapeutically competitive and regulatory environment.
  • Its current retail price ranges from $[value] to $[value] per unit.
  • Patent expiration in [year] is poised to trigger significant generic price reduction.
  • Future prices will depend heavily on patent status, market demand, and competition.
  • Price projections suggest a decrease post-2023, with possible stabilization or uplift from new indications or formulations.

FAQs

1. When is patent expiry for NDC 00378-0053?
Patent protections are set to expire in [year], enabling generic entry.

2. What factors could disrupt the projected price decline?
Market shifts, additional FDA approvals, or shortages of alternative therapies could sustain higher prices longer than anticipated.

3. How does generic entry typically affect pricing?
Generic competition can decrease prices by 60-80% within 6-12 months of market entry.

4. Are biosimilars relevant for this drug?
If the drug is biologic-based, biosimilars may enter the market post-patent expiry, influencing prices.

5. What is the main driver of future demand?
Expansion of indications and adoption in clinical practice primarily drive demand.


Citations
[1] IQVIA, "Medicine Use and Spending in the U.S.," 2022.
[2] FDA, "Drug Approvals and Patent Data," 2022-2023.
[3] Medtech Insight, "Generic Entry and Pricing," 2022.
[4] CMS, "Reimbursement Policies," 2022.
[5] MarketWatch, "Pharmaceutical Market Forecasts," 2022.

Note: Specific pharmaceutical name, indications, and market figures require confirmation from proprietary databases or regulatory filings as applicable.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.